Use of recombinant factor VIIa for uncontrolled bleeding in neonates after cardiopulmonary bypass

Paediatric Anaesthesia

Volumn 19, Issue 4, 2009, Pages 364-370

  Guzzetta, Nina A ^a,d   Huch, Shane ^c   Fernandez, Janet D ^b   Tosone, Steven R ^a   Miller, Bruce E ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b PHILADELPHIA COLLEGE OF OSTEOPATHIC MEDICINE   (United States)

^c Cardiac Research Department   (United States)

^d Department of Anesthesiology ^*  (United States)

Author keywords

Cardiac surgery; Cardiopulmonary bypass; Neonate; Recombinant activated factor VII; Uncontrolled bleeding

Indexed keywords

FRESH FROZEN PLASMA; RECOMBINANT BLOOD CLOTTING FACTOR 7A;

ARTICLE; CARDIOPULMONARY BYPASS; CLINICAL ARTICLE; CONGENITAL HEART DISEASE; ERYTHROCYTE TRANSFUSION; EXTRACORPOREAL OXYGENATION; HEMODIALYSIS; HUMAN; INTENSIVE CARE UNIT; NEWBORN; NEWBORN MORTALITY; PERITONEAL DIALYSIS; PEROPERATIVE CARE; POSTOPERATIVE CARE; POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; PROTHROMBIN TIME; RETROSPECTIVE STUDY; THROMBOCYTE TRANSFUSION; THROMBOSIS; TREATMENT OUTCOME; TUBE;

BLOOD TRANSFUSION; CARDIOPULMONARY BYPASS; EXTRACORPOREAL MEMBRANE OXYGENATION; FACTOR VIIA; FEMALE; HUMANS; INFANT, NEWBORN; MALE; PERITONEAL DIALYSIS; PLATELET COUNT; POSTOPERATIVE COMPLICATIONS; POSTOPERATIVE HEMORRHAGE; PROTHROMBIN TIME; RECOMBINANT PROTEINS; RENAL DIALYSIS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 62549095288     PISSN: 11555645     EISSN: 14609592     Source Type: Journal    
DOI: 10.1111/j.1460-9592.2008.02905.x     Document Type: Article

References (25)

1. Steiner ME, Key NS, Levy JH. Activated recombinant factor VII in cardiac surgery. Curr Opin Anaesthesiol 2005 18 : 89 92.
2. Ekert H, Brizard C, Eyers R et al. Elective administration in infants of low-dose recombinant activated factor VII (rFVIIa) in cardiopulmonary bypass surgery for congenital heart disease does not shorten time to chest closure or reduce blood loss and need for transfusions: a randomized, double-blind, parallel group, placebo-controlled study of rFVIIa and standard haemostatic replacement therapy versus standard haemostatic replacement therapy. Blood Coagul Fibrinolysis 2006 17 : 389 395.
3. Hedner U. Treatment of patients with factor VIII and factor IX inhibitors with special focus on the use of recombinant factor VIIa. Thromb Haemost 1999 82 : 531 539.
4. Midathada MV, Mehta P, Waner M et al. Recombinant factor VIIa in the treatment of bleeding. Am J Clin Pathol 2004 121 : 124 137.
5. Aldouri M. The use of recombinant factor VIIa in controlling surgical bleeding in non-haemophiliac patients. Pathophysiol Haemost Thromb 2002 32 : 41 46.
6. Hyllner M, Houltz E, Jeppsson A. Recombinant activated factor VII in the management of life-threatening bleeding in cardiac surgery. Eur J Cardiothorac Surg 2005 28 : 254 258.
7. ®) as a hemostatic agent after surgery for congenital heart disease. Paediatr Anaesth 2005 15 : 235 240.
8. Egan JR, Lammi A, Schell DN et al. Recombinant activated factor VII in paediatric cardiac surgery. Intensive Care Med 2004 30 : 682 685.
9. Veldman A, Neuhaeuser C, Akintuerk H et al. rFVIIa in the treatment of persistent hemorrhage in pediatric patients on ECMO following surgery for congenital heart disease. Paediatr Anaesth 2007 17 : 1176 1181.
10. Monroe DM, Hoffman M, Allen GA et al. The factor VII- platelet interplay: effectiveness of recombinant factor VIIa in the treatment of bleeding in severe thrombocytopathia. Semin Thromb Haemost 2000 26 : 373 377.
11. Lisman T, De Groot G. Mechanism of action of recombinant factor VIIa. J Thromb Haemost 2003 1 : 1138 1139.
12. Bladbjerg EM, Jespersen J. Activity of recombinant factor VIIa under different conditions in vitro: effect of temperature, pH, and haemodilution. Blood Coagul Fibrinolysis 2008 19 : 369 374.
13. Pychynska-Pokorska M, Moll JJ, Krajewski W et al. The use of recombinant coagulation factor VIIa in uncontrolled postoperative bleeding in children undergoing cardiac surgery with cardiopulmonary bypass. Pediatr Crit Care Med 2004 5 : 246 250.
14. Tobias JD, Simsic JM, Weinstein S et al. Recombinant factor VIIa to control excessive bleeding following surgery for congenital heart disease in pediatric patients. J Intensive Care Med 2004 19 : 270 273.
15. Tobias JD, Berkenbosch JW, Russo P. Recombinant factor VIIa to treat bleeding after cardiac surgery in an infant. Pediatr Crit Care Med 2003 4 : 49 51.
16. Mitsiakos G, Papaioannou G, Giougi E et al. Is the use of rFVIIa safe and effective in bleeding neonates? A retrospective series of 8 cases. J Pediatr Hematol Oncol 2007 29 : 145 150.
17. Roberts HR, Monroe DM, Hoffman M. Safety profile of recombinant factor VIIa. Semin Hematol 2004 41 : 101 108.
18. Konia MR, Liu H. The role of the recombinant factor VIIa during cardiac surgery in the post-aprotinin era. SCA Newsletter April 2008 7.
19. Lindley CM, Sawyer WT, Macik BG et al. Pharmacokinetics and pharmacodynamic of recombinant factor VIIa. Clin Pharmacol Ther 1994 55 : 638 648.
20. Klitgaard T, Nielsen TG. Overview of the human pharmacokinetics of recombinant activated factor VII. Br J Clin Pharmacol 2008 65 : 3 11.
21. Dietrich W, Spannagl M. Caveat against the use of activated recombinant factor VII for intractable bleeding in cardiac surgery. Anesth Analg 2002 94 : 1369 1370.
22. Agarwal HS, Bennett JE, Churchwell KB et al. Recombinant factor seven therapy for postoperative bleeding in neonatal and pediatric cardiac surgery. Ann Thorac Surg 2007 84 : 161 168.
23. Muntean W. Coagulation and anticoagulation in extracorporeal membrane oxygenation. Artif Organs 1999 23 : 979 983.
24. Mehta U, Laks H, Sadeghi A et al. Extracorporeal membrane oxygenation for cardiac support in pediatric patients. Am Surg 2000 66 : 879 886.
25. Chertow GM, Levy EM, Hammermeister KE et al. Independent association between acute renal failure and mortality following cardiac surgery. Am J Med 1998 104 : 343 348.